M F Segers

471 total citations
24 papers, 386 citations indexed

About

M F Segers is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, M F Segers has authored 24 papers receiving a total of 386 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Radiology, Nuclear Medicine and Imaging, 6 papers in Pulmonary and Respiratory Medicine and 6 papers in Genetics. Recurrent topics in M F Segers's work include Monoclonal and Polyclonal Antibodies Research (7 papers), Ovarian cancer diagnosis and treatment (5 papers) and Estrogen and related hormone effects (5 papers). M F Segers is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (7 papers), Ovarian cancer diagnosis and treatment (5 papers) and Estrogen and related hormone effects (5 papers). M F Segers collaborates with scholars based in Netherlands. M F Segers's co-authors include Chris M.G. Thomas, Theo Wobbes, Lambert G. Poels, Th. Wobbes, F. M. Nagengast, Peter Kenemans, Otto C. Boerman, Yvonne T. van der Schouw, W.H. Doesburg and Wim P.J. Witjes and has published in prestigious journals such as Cancer, Endocrinology and British Journal of Cancer.

In The Last Decade

M F Segers

24 papers receiving 361 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M F Segers Netherlands 11 98 84 84 81 64 24 386
Zbigniew Kojs Poland 12 74 0.8× 115 1.4× 124 1.5× 85 1.0× 129 2.0× 70 453
G. Crombach Germany 13 78 0.8× 25 0.3× 26 0.3× 49 0.6× 144 2.3× 48 433
Y Kawashima Japan 9 168 1.7× 53 0.6× 72 0.9× 61 0.8× 57 0.9× 43 489
Thanasak Sueblinvong Thailand 13 102 1.0× 19 0.2× 46 0.5× 89 1.1× 100 1.6× 25 456
Karim ElSahwi United States 12 134 1.4× 52 0.6× 52 0.6× 167 2.1× 119 1.9× 25 527
Zoltán Hernádi Hungary 13 142 1.4× 34 0.4× 18 0.2× 129 1.6× 168 2.6× 40 508
Tsunetada Yazaki Japan 13 170 1.7× 187 2.2× 12 0.1× 93 1.1× 64 1.0× 58 497
John Tziotis Greece 11 88 0.9× 38 0.5× 12 0.1× 24 0.3× 63 1.0× 17 329
Arighno Das United States 11 93 0.9× 100 1.2× 25 0.3× 75 0.9× 40 0.6× 26 368
I Richmond United Kingdom 13 64 0.7× 221 2.6× 16 0.2× 52 0.6× 75 1.2× 24 521

Countries citing papers authored by M F Segers

Since Specialization
Citations

This map shows the geographic impact of M F Segers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M F Segers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M F Segers more than expected).

Fields of papers citing papers by M F Segers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M F Segers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M F Segers. The network helps show where M F Segers may publish in the future.

Co-authorship network of co-authors of M F Segers

This figure shows the co-authorship network connecting the top 25 collaborators of M F Segers. A scholar is included among the top collaborators of M F Segers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M F Segers. M F Segers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thomas, C.M.G., et al.. (1996). The use of ‘ultrasensitive’ prostate‐specific antigen assays in the detection of biochemical recurrence after radical prostatectomy. British Journal of Urology. 77(3). 418–422. 12 indexed citations
2.
Massuger, L.F.A.G., et al.. (1995). Humoral anti-OV-TL 3 response after the intravenous administration of radiolabelled Fab' or F(ab')2 fragments in ovarian cancer patients. Nuclear Medicine Communications. 16(10). 853–859. 6 indexed citations
3.
Thomas, Chris M.G., L.F.A.G. Massuger, M F Segers, et al.. (1995). Analytical and clinical performance of improved Abbott IMx CA 125 assay: comparison with Abbott CA 125 RIA. Clinical Chemistry. 41(2). 211–216. 10 indexed citations
4.
Wobbes, Th., et al.. (1994). The phase of the menstrual cycle has no influence on the disease-free survival of patients with mammary carcinoma. British Journal of Cancer. 69(3). 599–600. 22 indexed citations
5.
6.
7.
Schouw, Yvonne T. van der, et al.. (1992). Comparison of four serum tumour markers in the diagnosis of colorectal carcinoma. British Journal of Cancer. 66(1). 148–154. 47 indexed citations
8.
Massuger, L.F.A.G., Chris M.G. Thomas, M F Segers, et al.. (1992). Specific and nonspecific immunoassays to detect HAMA after administration of indium-111-labeled OV-TL 3 F(ab')2 monoclonal antibody to patients with ovarian cancer.. PubMed. 33(11). 1958–63. 8 indexed citations
9.
10.
11.
Boerman, Otto C., M F Segers, Lambert G. Poels, Peter Kenemans, & Chris M.G. Thomas. (1990). Heterophilic antibodies in human sera causing falsely increased results in the CA 125 immunofluorometric assay. Clinical Chemistry. 36(6). 888–891. 55 indexed citations
12.
13.
Hein, P.R., et al.. (1989). Serum Hormone Levels in Pregnant Cynomolgus Monkeys. Journal of Medical Primatology. 18(2). 133–142. 15 indexed citations
14.
15.
Thomas, Chris M.G. & M F Segers. (1988). Measurement of serum human lutropin (hLH): hCG-interference evaluated for two hLH-specific IRMA kits.. Clinical Chemistry. 34(4). 768–768. 3 indexed citations
16.
Thomas, Chris M.G., et al.. (1987). Measurement of serum estradiol: comparison of three "direct" radioimmunoassays and effects of organic solvent extraction.. Clinical Chemistry. 33(10). 1946–1947. 15 indexed citations
17.
Boerman, Otto C., Chris M.G. Thomas, M F Segers, et al.. (1987). Time-resolved immunofluorometric assay for the ovarian carcinoma-associated antigenic determinant CA 125 in serum.. Clinical Chemistry. 33(12). 2191–2194. 9 indexed citations
18.
Thomas, Chris M.G., et al.. (1986). Comparison of the Analytical Characteristics of Ten Urinary hCG Tests for Early Pregnancy Diagnosis. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 23(2). 216–222. 8 indexed citations
19.
Thomas, Chris M.G., et al.. (1985). Comparison of the Analytical Characteristics and Clinical Usefulness in Tumour Monitoring of Fifteen hCG(-β) Immunoassay Kits. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 22(3). 236–246. 29 indexed citations
20.
Loeber, J.G., et al.. (1978). Spontaneous Dissociation of Human Pituitary Luteinizing Hormone in Solution*. Endocrinology. 103(6). 2240–2246. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zbigniew Kojs Breakdown of academic impact, for papers by G. Crombach Breakdown of academic impact, for papers by Y Kawashima Breakdown of academic impact, for papers by Thanasak Sueblinvong Breakdown of academic impact, for papers by Karim ElSahwi Breakdown of academic impact, for papers by Zoltán Hernádi Breakdown of academic impact, for papers by Tsunetada Yazaki Breakdown of academic impact, for papers by John Tziotis Breakdown of academic impact, for papers by Arighno Das Breakdown of academic impact, for papers by I Richmond
Rankless by CCL
2026